1
|
Vinggaard A, Lamoree M, Escher B, Antignac JP, Scholze M, Jensen T, Herzler M, Audebert M, Hamers T, Kortenkamp A, Busquet F, Piumatti M, Dervilly G, Valente M, Cariou R, Moteau S, Oelgeschläger M, Renko K, Schmeisser S, Maier D, Laursen L. P15-08 PANORAMIX: Providing risk assessments of complex real-life mixtures for the protection of Europe’s citizens and the environment. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07.589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
2
|
Weber A, Birk B, Mueller C, Huener HA, Renko K, Coecke S, Schneider S, Van Ravenzwaay B, Funk-Weyer D, Landsiedel R. Validation and specificity testing of an in vitro method assessing substance-induced DIO1 inhibition in human liver microsomes. Toxicol Lett 2021. [DOI: 10.1016/s0378-4274(21)00494-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
3
|
Fischer B, Heise T, Ritz V, Marx-Stoelting P, Oles P, Renko K, Feiertag K, Marzo Solano M. In vitro and in vivo thyroid evaluations after exposure to mixtures of triazole fungicides. Toxicol Lett 2021. [DOI: 10.1016/s0378-4274(21)00753-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
4
|
Šošić-Jurjević B, Lütjohann D, Renko K, Filipović B, Radulović N, Ajdžanović V, Trifunović S, Nestorović N, Živanović J, Manojlović Stojanoski M, Kӧhrle J, Milošević V. The isoflavones genistein and daidzein increase hepatic concentration of thyroid hormones and affect cholesterol metabolism in middle-aged male rats. J Steroid Biochem Mol Biol 2019; 190:1-10. [PMID: 30885834 DOI: 10.1016/j.jsbmb.2019.03.009] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/08/2018] [Revised: 03/06/2019] [Accepted: 03/13/2019] [Indexed: 01/05/2023]
Abstract
We examined whether isoflavones interfere with thyroid homeostasis, increase hepatic thyroid hormone concentrations and affect cholesterol metabolism in middle-aged (MA) male rats. Thirteen-month-old Wistar rats were injected subcutaneously with 35 mg/kg b.w./day of genistein, daidzein or vehicle (controls) for four weeks. Hepatic Dio1 gene expression was up-regulated by 70% (p < 0.001 for both) and Dio1 enzyme activity increased by 64% after genistein (p < 0.001) and 73% after daidzein treatment (p < 0.0001). Hepatic T3 was 75% higher (p < 0.05 for both), while T4 increased only after genistein treatment. Serum T4 concentrations were 31% lower in genistein- and 49% lower in dadzein-treated rats (p < 0.001 for both) compared with controls. Hepatic Cyp7a1 gene expression was up-regulated by 40% after genistein and 32% after daidzein treatment (p < 0.05 for both), in agreement with a 7α-hydroxycholesterol increase of 50% (p < 0.01) and 88% (p < 0.001), respectively. Serum 24- and 27-hydroxycholesterol were 30% lower (p < 0.05 for both), while only 24-hydroxycholesterol was decreased in the liver by 45% after genistein (p < 0.05) and 39% (p < 0.01) after dadzein treatment. Serum concentration of the cholesterol precursor desmosterol was 32% (p < 0.05) lower only after dadzein treatment alone, while both isoflavones elevated this parameter in the liver by 45% (p < 0.01). In conclusion, isoflavones increased T3 availability in the liver of MA males, despite decreasing serum T4. Hepatic increase of T3 possibly contributes to activation of the neutral pathway of cholesterol degradation into bile acids in the liver. While isoflavones obviously have the potential to trigger multiple mechanisms involved in cholesterol metabolism and oxysterol production, they failed to induce any hypocholesterolemic effect.
Collapse
Affiliation(s)
- B Šošić-Jurjević
- Institute for Biological Research, "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia.
| | - D Lütjohann
- Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, D-53127 Bonn, Germany
| | - K Renko
- Institut für Experimentelle Endokrinologie, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany
| | - B Filipović
- Institute for Biological Research, "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| | - N Radulović
- Department of Chemistry, Faculty of Science and Mathematics, University of Niš, Višegradska 33, 18000 Niš, Serbia
| | - V Ajdžanović
- Institute for Biological Research, "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| | - S Trifunović
- Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, D-53127 Bonn, Germany
| | - N Nestorović
- Institute for Biological Research, "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| | - J Živanović
- Institute for Biological Research, "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| | - M Manojlović Stojanoski
- Institute for Biological Research, "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| | - J Kӧhrle
- Institut für Experimentelle Endokrinologie, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany
| | - V Milošević
- Institute for Biological Research, "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| |
Collapse
|
5
|
Stoedter M, Renko K, Ibáñez E, Plano D, Becker NP, Martitz J, Palop JA, Calvo A, Sanmartín C, Schomburg L. Strong induction of iodothyronine deiodinases by chemotherapeutic selenocompounds. Metallomics 2015; 7:347-54. [PMID: 25579002 DOI: 10.1039/c4mt00273c] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The biological activity of thyroid hormones (TH) is regulated by selenoenzymes of the iodothyronine deiodinase (DIO) family catalysing TH activating and inactivating reactions. Besides TH metabolism, several studies indicate an important role of DIO isoenzymes in tumorigenesis and cancer growth. It is therefore of therapeutic importance to identify modulators of DIO expression. We have synthesized and studied a series of selenocompounds containing a methyl- or benzyl-imidoselenocarbamate backbone. One of these novel compounds had chemotherapeutic activities in a murine xenograft tumour model by an unknown mechanism. Therefore, we tested their effects on DIO expression in vitro. In HepG2 hepatocarcinoma cells, DIO1 activity was strongly (up to 10-fold) increased by the methyl- but not by the corresponding benzyl-imidoselenocarbamates. Steady-state mRNA levels remained unaltered under these conditions indicating a post-transcriptional mode of action. The effects were further characterized in HEK293 cells stably expressing DIO1, DIO2 or DIO3. Even within the artificial genetic context of the expression vectors, all three DIO isoenzymes were up-regulated by the methyl- and to a lesser extent by the benzyl-imidoselenocarbamates. Consistent stimulating effects were observed with methyl-N,N'-di(quinolin-3-ylcarbonyl)-imidoselenocarbamate (EI201), a selenocompound known for its anti-tumour activity. DIO inducing effects were unrelated to the intracellular accumulation of selenium, yet the precise mode of action remains elusive. Collectively, our data highlight that these selenocompounds may constitute interesting pharmacological compounds for modifying DIO expression potentially affecting the balance between cell differentiation and proliferation.
Collapse
Affiliation(s)
- M Stoedter
- Institut für Experimentelle Endokrinologie, Charité - Universitätsmedizin Berlin, CVK, Südring 10, D-13353 Berlin, Germany.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Martitz J, Becker NP, Renko K, Stoedter M, Hybsier S, Schomburg L. Gene-specific regulation of hepatic selenoprotein expression by interleukin-6. Metallomics 2015; 7:1515-21. [PMID: 26399395 DOI: 10.1039/c5mt00211g] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Sepsis is a severe inflammatory disease resulting in excessive production of pro-inflammatory cytokines including interleukin-6 (IL-6), causing oxidative stress, tissue damage and organ dysfunction. Health benefits have been observed upon selenium (Se) supplementation in severe sepsis. Selenium is incorporated into selenoproteins implicated in anti-oxidative defence, thyroid hormone metabolism and immunoregulation. Selenium metabolism is controlled by hepatocytes synthesizing and secreting the Se transporter selenoprotein P (SePP). The circulating SePP declines in sepsis causing low serum Se levels. Dysregulation of the hepatic selenoenzyme deiodinase type 1 (DIO1) potentially contributes to the low T3 (thyroid hormone) syndrome observed in severe diseases. We hypothesized that IL-6 affects hepatic selenoprotein biosynthesis directly. Testing human hepatocytes in culture, IL-6 reduced the concentrations of SePP mRNA and secreted SePP in a dose-dependent manner. In parallel, expression of DIO1 declined at the mRNA, protein and enzyme activity level. The effects of IL-6 on glutathione peroxidase (GPX) expression were isozyme-specific; GPX1 remained unaffected, while transcript concentrations of GPX2 increased and those of GPX4 decreased. This pattern of IL-6-dependent effects was mirrored in reporter gene experiments with SePP, DIO1, GPX1, and GPX2 promoter constructs pointing to direct transcriptional effects of IL-6. The redirection of hepatic selenoprotein biosynthesis by IL-6 may represent a central regulatory circuit responsible for the decline of serum Se and low T3 concentrations in sepsis. Accordingly, therapeutic IL-6 targeting may be effective for improving the Se and thyroid hormone status, adjuvant Se supplementation success and survival in sepsis.
Collapse
Affiliation(s)
- J Martitz
- Institut für Experimentelle Endokrinologie, Charité- Universitätsmedizin Berlin, CVK, Südring 10, D-13353 Berlin, Germany.
| | | | | | | | | | | |
Collapse
|
7
|
Šošić-Jurjević B, Filipović B, Renko K, Miler M, Trifunović S, Ajdžanovič V, Kӧhrle J, Milošević V. Testosterone and estradiol treatments differently affect pituitary-thyroid axis and liver deiodinase 1 activity in orchidectomized middle-aged rats. Exp Gerontol 2015; 72:85-98. [PMID: 26384168 DOI: 10.1016/j.exger.2015.09.010] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2015] [Revised: 09/09/2015] [Accepted: 09/10/2015] [Indexed: 11/16/2022]
Abstract
We previously reported that orchidectomy (Orx) of middle-aged rats (15-16-month-old; MA) slightly affected pituitary-thyroid axis, but decreased liver deiodinase (Dio) type 1 and pituitary Dio2 enzyme activities. At present, we examined the effects of subsequent testosterone-propionate treatment (5mg/kg; Orx+T), and compared the effects of testosterone with the effects of estradiol-dipropionate (0.06mg/kg; Orx+E) treatment. Hormones were subcutaneously administered, daily, for three weeks, while Orx and sham-operated (SO) controls received only the vehicle. The applied dose of T did not alter serum TSH, T4 and T3 concentrations in Orx- MA, though it increased TSH when administrated to Orx young adults (2.5-month-old; Orx-YA). However, pituitaries of Orx-MA+T rats had higher relative intensity of immunofluorescence (RIF) for TSHβ; in their thyroids we found increased volume and height of follicular epithelium, decreased volume of the colloid and higher RIF for T4-bound to thyroglobulin (Tg-T4). Liver Dio1 activity was increased. E-treatment did not affect serum hormone levels, pituitary RIF for TSHβ, or liver Dio1 activity in Orx-MA rats. Thyroids had decreased relative volume and height of follicular epithelium, increased relative volume of the colloid, decreased volume of sodium-iodide symporter-immunopositive epithelium and lower RIF for Tg-T4. Detected changes were statistically significant. In conclusion, androgenization enhanced pituitary TSHβ RIF, thyroid activation and liver Dio1 enzyme activity in Orx-MA, without elevating serum TSH as in Orx-YA rats. Estrogenization induced pituitary enlargement with no effect on pituitary TSHβ RIF, serum TSH or liver Dio1 activity. E also induced alterations in thyroid histology that indicate mild suppression of its functioning, and contributed to thyroid blood vessel enlargement in Orx-MA rats.
Collapse
Affiliation(s)
- B Šošić-Jurjević
- Institute for Biological Research "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia.
| | - B Filipović
- Institute for Biological Research "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| | - K Renko
- Institut für Experimentelle Endokrinologie, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany
| | - M Miler
- Institute for Biological Research "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| | - S Trifunović
- Institute for Biological Research "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| | - V Ajdžanovič
- Institute for Biological Research "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| | - J Kӧhrle
- Institut für Experimentelle Endokrinologie, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany
| | - V Milošević
- Institute for Biological Research "Siniša Stanković", University of Belgrade, Despot Stefan Blvd. 142, 11000 Belgrade, Serbia
| |
Collapse
|
8
|
Martitz J, Becker NP, Renko K, Stoedter M, Hybsier S, Schomburg L. IL-6 affects expression of deiodinases directly thereby potentially contributing to the low T3-syndrome. Exp Clin Endocrinol Diabetes 2015. [DOI: 10.1055/s-0035-1547680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
Renko K, Jayarama-Naidu R, Johannes J, Schomburg L, Köhrle J. Establishment of a non-isotopic activity assay for thyroid hormone transporters. Exp Clin Endocrinol Diabetes 2015. [DOI: 10.1055/s-0035-1547745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
10
|
Renko K, Hoefig CS, Both S, Braun D, Welsink T, Schomburg L, Köhrle J. Screening assays on inhibitors, modulators and substrates of deiodinase and dehalogenase activities. Exp Clin Endocrinol Diabetes 2014. [DOI: 10.1055/s-0034-1372314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|